CTTH

CTT PHARMACEUTICAL HOLDINGS, INC.

Latest Form 4:Purchase$590byCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) · filed Aug 19, 2026

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) has 6 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 19, 2026.

The most active filer is CEO CTT PHARMACEUTICAL HOLDINGS, INC. with 5 filings.

  • Industry:Medical - Pharmaceuticals
  • CEO:Ryan Khouri
  • Employees:1
  • HQ:Tampa, FL, US
  • IPO:1997-04-18

Insider Buying

$12K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Source
Purchase$590Aug 19SEC ↗
Purchase$112Aug 14SEC ↗
Purchase$501Aug 10SEC ↗
Purchase$457Dec 17SEC ↗
Purchase$11KNov 24SEC ↗

Related companies

CTT PHARMACEUTICAL HOLDINGS, INC. is in the Healthcare sector.